Regado BioSciences, Inc. (TBRA)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

701 GATEWAY BLVD SOUTH SAN FRANCISCO, CA 94080

Regado Bioscience, Inc. develops biopharmaceutical therapies. The Company discovers and researches injectable anti-thrombotics, including anticoagulants and antiplatelet agents, for the treatment of acute coronary syndrome, percutaneous coronary intervention, and coronary artery bypass grafting.

Are you looking for this stock instead?

View SEC Filings from TBRA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TBRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PODLESAK DENNIS

  • Director
No longer subject to file 2016-11-01 0

LEGAULT PIERRE

  • Director
No longer subject to file 2016-11-01 0

FROMKIN ANDREW J.

  • Director
No longer subject to file 2016-11-01 0

BROSGART CAROL L

  • Director
No longer subject to file 2016-11-01 0

FISCHER LAURENT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2016-11-01 0

FRAZIER HEALTHCARE V, LP

  • 10% Owner
No longer subject to file 2016-11-01 0

HERON PATRICK J

  • Director
No longer subject to file 2016-11-01 0

COOPER JEFFREY H

  • Director
No longer subject to file 2016-11-01 0

LEFEBVRE ERIC CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-11-01 0

JENKINS HELEN CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2016-11-01 0

PEETZ CHRISTOPHER CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2016-11-01 0

MELINCOFF GWEN A

  • Director
No longer subject to file 2016-11-01 0

WEBER ECKARD

  • Director
No longer subject to file 2016-11-01 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
No longer subject to file 2016-11-01 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2016-11-01 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2016-11-01 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
No longer subject to file 2016-11-01 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • 10% Owner
No longer subject to file 2016-11-01 0

PENTWATER CAPITAL MANAGEMENT LP

3,758,200 2016-10-31 0

ALLERGAN PLC

ALLERGAN HOLDCO US, INC.

SAPPHIRE ACQUISITION CORP.

  • 10% Owner
0 2016-09-19 0

NOVO A/S

  • 10% Owner
No longer subject to file 2016-07-11 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
3,553,322 2015-05-04 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
47,613 2015-05-04 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • 10% Owner
38,094 2015-05-04 0

NEFF P SHERRILL

  • Director
0 2015-01-01 0

GOPKA ANTON

  • Director
0 2015-01-01 0

TREU JESSE I

  • Director
  • 10% Owner
0 2015-01-01 0

CLARK B. JEFFERSON

  • Director
0 2015-01-01 0

MENDELSOHN MICHAEL

  • Director
0 2015-01-01 0

ELSEY R DON SR. VP/CHIEF FINANCIAL OFFICER

  • Officer
0 2015-01-01 0

SHAH NIMESH

  • 10% Owner
38,094 2015-01-01 0

METZGER MICHAEL A PRESIDENT & CEO

  • Officer
  • Director
0 2014-12-03 0

KIERLIN ROBERT A

  • 10% Owner
No longer subject to file 2014-10-24 0

PELLICCIONE NICHOLAS J. SR. VP OF REGULATORY AFFAIRS

  • Officer
0 2014-05-21 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2014-03-21 0

WISNIEWSKI RAPHAEL

  • Director
0 2014-01-01 0

GIAQUINTO ALEXANDER R CCO, SVP OF REG. AFFAIRS

  • Officer
0 2014-01-01 0

RUSCONI CHRISTOPHER PAUL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-01-01 0

MAZZO DAVID J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2014-01-01 0

COURTS CHRISTOPHER VICE PRESIDENT OF FINANCE

  • Officer
0 2014-01-01 0

ZELENKOFSKE STEVEN SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2014-01-01 0

MCDONALD ELLEN SVP & CHIEF BUSINESS OFFICER

  • Officer
0 2013-08-27 0

BLAIR JAMES C

  • 10% Owner
2,603,208 2013-08-27 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
2,571,117 2013-08-27 0

RMI INVESTMENTS S.A.R.L.

RUSNANOMEDINVEST LLC

  • 10% Owner
5,236,517 2013-08-27 0

DOVEY BRIAN H

  • 10% Owner
2,603,208 2013-08-27 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
14,920 2013-08-27 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
2,603,208 2013-08-27 0

VITULLO NICOLE

  • 10% Owner
2,603,208 2013-08-27 0

BIODISCOVERY 3, FCPR

EDMOND DE ROTHSCHILD INVESTMENT PARTNERS

  • 10% Owner
2,407,271 2013-08-27 0

QUAKER BIO VENTURES LP

QUAKER BIOVENTURES CAPITAL LP

  • 10% Owner
1,294,021 2013-08-27 0

DOMAIN ASSOCIATES

  • 10% Owner
17,171 2013-08-21 0

HALAK BRIAN K

  • 10% Owner
17,171 2013-08-21 0

KAMDAR KIM P.

  • 10% Owner
17,171 2013-08-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WISNIEWSKI RAPHAEL - Director - > 10% Owner

2013-08-29 12:37:27 -0400 2023-08-27 A 17,964 a 17,964 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments